Source:http://linkedlifedata.com/resource/pubmed/id/10581129
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
24
|
| pubmed:dateCreated |
2000-2-11
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0195-668X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
20
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1761-3
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:10581129-Adrenergic beta-1 Receptor Antagonists,
pubmed-meshheading:10581129-Adrenergic beta-Antagonists,
pubmed-meshheading:10581129-Death, Sudden, Cardiac,
pubmed-meshheading:10581129-Heart Failure,
pubmed-meshheading:10581129-Humans,
pubmed-meshheading:10581129-Metoprolol,
pubmed-meshheading:10581129-Prognosis,
pubmed-meshheading:10581129-Stroke Volume,
pubmed-meshheading:10581129-Survival Rate
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
The merit of beta(1)-blockade in heart failure.
|
| pubmed:publicationType |
Editorial,
Review
|